Indigo Ag Launches biotrinsic® Nemora FP™ for Soybean Farmers

Indigo Ag Launches biotrinsic® Nemora FP™ for Soybean Farmers



On October 6, 2025, Indigo Ag, Inc. marked a significant advancement in agricultural biotechnology with the introduction of biotrinsic® Nemora FP™. This revolutionary seed treatment is designed specifically for soybean crops to combat the soybean cyst nematode (SCN), a notorious pest that poses a substantial threat to yield potential for farmers in the United States and Canada.

Nemora FP™ is an EPA-registered bionematicide that boasts unique anti-hatch technology. Unlike many chemical alternatives, Nemora functions without harming the soybean plants or their underlying soil health. According to Dr. Jon Giebel, VP of North America Commercial - Biologicals at Indigo Ag, this innovative product has been extensively tested to improve plant health and yield while promoting soil sustainability.

How Nemora Works



This biological treatment employs a specific strain of Pseudomonas oryzihabitans bacteria, which plays a crucial role in colonizing the roots and shoots of soybean plants. Within weeks of application, the bacteria multiply around the plant roots, enhancing overall growth and effectively combating SCN. By preventing nematode eggs from hatching, Nemora effectively disrupts the lifecycle of SCN, leading to an average reduction of up to 68% in egg hatching rates. This targeted action significantly contributes to higher yields and better crop health.

In addition to disrupting nematode populations, Nemora fosters a thriving community of beneficial bacteria vital for plant development. This is crucial for fostering long-term agricultural resilience where conventional treatments may falter.

Promising Results for Farmers



Farmers using Nemora FP™ can expect notable benefits such as:
  • - Improved root structure, longer tap roots, and increased root biomass.
  • - Enhanced plant shoots and healthier plant emergence.
  • - No adverse effects on plant nodulation, essential for nitrogen fixation.
  • - Comparable yield advantages to conventional chemical solutions, all without the associated phytotoxicity.

Dr. Greg Tylka from Iowa State University emphasizes the importance of integrating biological treatments like Nemora into a multi-faceted approach to managing soybean crops against SCN. By prioritizing crop rotation, using SCN-resistant varieties, and implementing microbial treatments, farmers can create sustainable practices that mitigate yield loss effectively.

Availability and Adoption



Indigo Ag is encouraging farmers to collaborate with their local representatives to incorporate Nemora into their planting strategies for Spring 2026. This proactive approach not only supports current agricultural practices but also sets a precedent for future innovations in sustainable farming.

Founded in 2013, Indigo Ag operates in 18 countries, focusing on sustainable agricultural solutions that encompass both improving crop yields and the health of ecosystems. The introduction of Nemora FP™ fits seamlessly into Indigo's broader vision of leveraging science and innovation to tackle agricultural challenges while aligning with environmentally responsible practices.

By offering Nemora as an option, Indigo Ag is committed to helping farmers thrive in their efforts to yield profitable harvests without compromising on sustainability. As farming faces new challenges annually including pest resistance and climate variability, solutions like Nemora are paving the way for future agricultural breakthroughs.

In conclusion, biotrinsic® Nemora FP™ represents a forward-thinking strategy in the fight against SCN and highlights Indigo Ag's dedication to sustainable agriculture. By protecting crops and benefiting the ecosystem, Indigo is set to help farmers cultivate success in harmony with nature.

Topics Consumer Products & Retail)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.